86 related articles for article (PubMed ID: 29928781)
1. NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family.
Tröster A; Heinzlmeir S; Berger BT; Gande SL; Saxena K; Sreeramulu S; Linhard V; Nasiri AH; Bolte M; Müller S; Kuster B; Médard G; Kudlinzki D; Schwalbe H
ChemMedChem; 2018 Aug; 13(16):1629-1633. PubMed ID: 29928781
[TBL] [Abstract][Full Text] [Related]
2. The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis.
Martiny-Baron G; Holzer P; Billy E; Schnell C; Brueggen J; Ferretti M; Schmiedeberg N; Wood JM; Furet P; Imbach P
Angiogenesis; 2010 Sep; 13(3):259-67. PubMed ID: 20803239
[TBL] [Abstract][Full Text] [Related]
3. The Pyrazolo[3,4-
Neuber C; Tröster A; Löser R; Belter B; Schwalbe H; Pietzsch J
Molecules; 2020 Nov; 25(21):. PubMed ID: 33153234
[TBL] [Abstract][Full Text] [Related]
4. Optimization of the Lead Compound NVP-BHG712 as a Colorectal Cancer Inhibitor.
Tröster A; DiPrima M; Jores N; Kudlinzki D; Sreeramulu S; Gande SL; Linhard V; Ludig D; Schug A; Saxena K; Reinecke M; Heinzlmeir S; Leisegang MS; Wollenhaupt J; Lennartz F; Weiss MS; Kuster B; Tosato G; Schwalbe H
Chemistry; 2023 Apr; 29(23):e202203967. PubMed ID: 36799129
[TBL] [Abstract][Full Text] [Related]
5. The small molecule tyrosine kinase inhibitor NVP-BHG712 antagonizes ABCC10-mediated paclitaxel resistance: a preclinical and pharmacokinetic study.
Kathawala RJ; Wei L; Anreddy N; Chen K; Patel A; Alqahtani S; Zhang YK; Wang YJ; Sodani K; Kaddoumi A; Ashby CR; Chen ZS
Oncotarget; 2015 Jan; 6(1):510-21. PubMed ID: 25402202
[TBL] [Abstract][Full Text] [Related]
6. Structures of an Eph receptor tyrosine kinase and its potential activation mechanism.
Wei Q; Liu J; Wang N; Zhang X; Jin J; Chin-Sang I; Zheng J; Jia Z
Acta Crystallogr D Biol Crystallogr; 2014 Dec; 70(Pt 12):3135-43. PubMed ID: 25478832
[TBL] [Abstract][Full Text] [Related]
7. Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.
Noren NK; Lu M; Freeman AL; Koolpe M; Pasquale EB
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5583-8. PubMed ID: 15067119
[TBL] [Abstract][Full Text] [Related]
8. Eph-B4 mediates vein graft adaptation by regulation of endothelial nitric oxide synthase.
Wang M; Collins MJ; Foster TR; Bai H; Hashimoto T; Santana JM; Shu C; Dardik A
J Vasc Surg; 2017 Jan; 65(1):179-189. PubMed ID: 26817610
[TBL] [Abstract][Full Text] [Related]
9. Structure and thermodynamic characterization of the EphB4/Ephrin-B2 antagonist peptide complex reveals the determinants for receptor specificity.
Chrencik JE; Brooun A; Recht MI; Kraus ML; Koolpe M; Kolatkar AR; Bruce RH; Martiny-Baron G; Widmer H; Pasquale EB; Kuhn P
Structure; 2006 Feb; 14(2):321-30. PubMed ID: 16472751
[TBL] [Abstract][Full Text] [Related]
10. Fluorine-18 radiolabeling and radiopharmacological characterization of a benzodioxolylpyrimidine-based radiotracer targeting the receptor tyrosine kinase EphB4.
Mamat C; Mosch B; Neuber C; Köckerling M; Bergmann R; Pietzsch J
ChemMedChem; 2012 Nov; 7(11):1991-2003. PubMed ID: 23042640
[TBL] [Abstract][Full Text] [Related]
11. Structure-based optimization of potent and selective inhibitors of the tyrosine kinase erythropoietin producing human hepatocellular carcinoma receptor B4 (EphB4).
Lafleur K; Huang D; Zhou T; Caflisch A; Nevado C
J Med Chem; 2009 Oct; 52(20):6433-46. PubMed ID: 19788238
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of the tyrosine kinase EphB4. Part 4: Discovery and optimization of a benzylic alcohol series.
Barlaam B; Ducray R; Lambert-van der Brempt C; Plé P; Bardelle C; Brooks N; Coleman T; Cross D; Kettle JG; Read J
Bioorg Med Chem Lett; 2011 Apr; 21(8):2207-11. PubMed ID: 21441027
[TBL] [Abstract][Full Text] [Related]
13. Ephrin-As, Eph receptors and integrin α3 interact and colocalise at membrane protrusions of U251MG glioblastoma cells.
Makarov A; Ylivinkka I; Nyman TA; Hyytiäinen M; Keski-Oja J
Cell Biol Int; 2013 Oct; 37(10):1080-8. PubMed ID: 23686814
[TBL] [Abstract][Full Text] [Related]
14. Phosphoproteomic profiling of NSCLC cells reveals that ephrin B3 regulates pro-survival signaling through Akt1-mediated phosphorylation of the EphA2 receptor.
Ståhl S; Branca RM; Efazat G; Ruzzene M; Zhivotovsky B; Lewensohn R; Viktorsson K; Lehtiö J
J Proteome Res; 2011 May; 10(5):2566-78. PubMed ID: 21413766
[TBL] [Abstract][Full Text] [Related]
15. Specific Eph receptor-cytoplasmic effector signaling mediated by SAM-SAM domain interactions.
Wang Y; Shang Y; Li J; Chen W; Li G; Wan J; Liu W; Zhang M
Elife; 2018 May; 7():. PubMed ID: 29749928
[TBL] [Abstract][Full Text] [Related]
16. Experimental hypoxia does not influence gene expression and protein synthesis of Eph receptors and ephrin ligands in human melanoma cells in vitro.
Reissenweber B; Mosch B; Pietzsch J
Melanoma Res; 2013 Apr; 23(2):85-95. PubMed ID: 23358429
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of embryonic gene expression defines potential interaction sites for Xenopus EphB4 receptors with ephrin-B ligands.
Helbling PM; Saulnier DM; Robinson V; Christiansen JH; Wilkinson DG; Brändli AW
Dev Dyn; 1999 Dec; 216(4-5):361-73. PubMed ID: 10633856
[TBL] [Abstract][Full Text] [Related]
18. Eph/ephrin signalling serves a bidirectional role in lipopolysaccharide‑induced intestinal injury.
Xiong Y; Li KX; Wei H; Jiao L; Yu SY; Zeng L
Mol Med Rep; 2018 Aug; 18(2):2171-2181. PubMed ID: 29901151
[TBL] [Abstract][Full Text] [Related]
19. Expression of Eph receptors and their ligands, ephrins, during lipopolysaccharide fever in rats.
Ivanov AI; Steiner AA; Scheck AC; Romanovsky AA
Physiol Genomics; 2005 Apr; 21(2):152-60. PubMed ID: 15671251
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of erythropoietin-producing hepatoma receptor B4 (EphB4) signalling suppresses the vascularisation and growth of endometriotic lesions.
Rudzitis-Auth J; Fuß SA; Becker V; Menger MD; Laschke MW
Br J Pharmacol; 2020 Jul; 177(14):3225-3239. PubMed ID: 32144768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
